This bill amends R.S. 22:1029(B) to enhance insurance coverage for routine colorectal cancer screening in Louisiana. The definition of "routine colorectal cancer screening" is updated to include any test or screening that aligns with the latest recommendations from the American Cancer Society or the National Comprehensive Cancer Network, rather than being limited to specific tests like fecal occult blood tests, flexible sigmoidoscopy, or colonoscopy. Additionally, the bill clarifies that routine screenings do not include services excluded from coverage due to being classified as experimental or investigational by health coverage plans.

The changes also reflect a shift in terminology, replacing "shall mean" with "means" and "shall" with "does" to modernize the language of the law. These amendments aim to ensure that individuals have access to a broader range of colorectal cancer screening options based on current medical guidelines, thereby promoting early detection and potentially improving health outcomes for patients at risk.

Statutes affected:
HB361 Original: 22:1029(B)
HB361 Engrossed: 22:1029(B)
HB361 Reengrossed: 22:1029(B)
HB361 Enrolled: 22:1029(B)
HB361 Act : 22:1029(B)
HB361 Act: 22:1029(B)